Nov 27, 2021

Starpharma Releases Positive DEP® Phase 2 Interim Results In Prostate Cancer

British Herald reports on Starpharma's announcement, regarding the positive interim results from the prostate cancer cohort in its ongoing phase 2 trial of DEP^® cabazitaxel. Read the full article here. 

 This contains certain forward-looking statements.